改良Harborview风险评分可准确预测破裂性腹主动脉瘤患者死亡率
本研究利用2011至2018年NSQIP数据库1536例及单中心163例接受破裂性腹主动脉瘤修复术的患者,验证改良Harborview风险评分(HRS)的预测效能。改良HRS对年龄>76岁、肌酐>2 mg/dL、国际标准化比值>1.8及任一次收缩压<70 mmHg各赋1分。两个数据集间30天死亡率的受试者工作特征曲线下面积无差异(P=0.78),仅0分患者在两个数据集间死亡率差异有统计学意义(P=0.01)。
要点
- 改良HRS对破裂性腹主动脉瘤修复术后30天死亡率具有广泛适用的预测价值。
- NSQIP与单中心数据集的受试者工作特征曲线下面积无差异(P=0.78)。
- 仅0分患者死亡率在两个数据集间差异有统计学意义(P=0.01)。
核心结论
- 改良HRS被证实可作为破裂性腹主动脉瘤患者临床决策工具广泛适用,该简便模型应应用于所有破裂性腹主动脉瘤患者,以辅助医生和患者在决定修复术前进行决策。
研究设计与样本
- 纳入2011至2018年NSQIP数据库中所有接受破裂性腹主动脉瘤修复术的患者(1536例)及单家学术医疗中心接受同类手术的患者(163例)。
- 改良HRS赋分规则为:年龄>76岁、肌酐>2 mg/dL、国际标准化比值>1.8、任一次收缩压<70 mmHg,每项各1分。
- 主要结局为30天死亡率,计算受试者工作特征曲线下面积,采用Delong检验比较数据集间区分度,采用Pearson χ2检验比较各评分数据集间死亡率。
主要发现
- 共识别NSQIP患者1536例,机构数据集评估患者163例。
- 评分0分患者518例(NSQIP 455例,机构63例),1分676例(NSQIP 617例,机构59例),2分391例(NSQIP 364例,机构27例),3分106例(NSQIP 93例,机构13例),4分8例(NSQIP 7例,机构1例)。
- 两个数据集间受试者工作特征曲线下面积无差异(P=0.78)。
- 30天死亡率:0分NSQIP 10% vs 机构22%;1分NSQIP 28% vs 机构36%;2分NSQIP 41% vs 机构44%;3分NSQIP 45% vs 机构69%;4分NSQIP 57% vs 机构100%。
- 仅0分患者死亡率在两个数据集间差异有统计学意义(P=0.01)。
关键数值与推荐
- 改良HRS评分0分患者30天死亡率为NSQIP 10% vs 机构22%(P=0.01)。
- 改良HRS评分1分患者30天死亡率为NSQIP 28% vs 机构36%。
- 改良HRS评分2分患者30天死亡率为NSQIP 41% vs 机构44%。
- 改良HRS评分3分患者30天死亡率为NSQIP 45% vs 机构69%。
- 改良HRS评分4分患者30天死亡率为NSQIP 57% vs 机构100%。
临床怎么用
- 作者认为,该简便模型应应用于所有破裂性腹主动脉瘤患者,以辅助医生和患者在决定修复术前进行决策。
局限性
- 对评分为4分的患者进行比较分析受限于样本量小。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The modified Harborview Risk Score (HRS) is a simple measure initially derived from a single institutional dataset used to predict ruptured abdominal aortic aneurysm (rAAA) repair survival preoperatively using basic labs and vital signs collected upon presentation. However, validation of this widely applicable scoring system has not been performed. This study aims to validate this scoring system using a large multi-institutional database. METHODS: All patients who underwent repair of an rAAA from 2011 to 2018 in the National Surgical Quality Improvement Program (NSQIP) and at a single academic medical center were included. The modified HRS was calculated by assigning 1 point for each of the following: age >76 years, creatinine >2 mg/dL, international normalized ratio >1.8, and any systolic blood pressure less than 70 mmHg. Assessment of the prediction model was then completed. Using a primary outcome measure of 30-day mortality, the receiver operating characteristic area under the curve was calculated. The discrimination between datasets was compared using a Delong test. Mortality rates for each score were compared between datasets using the Pearson χ2 test. Comparative analysis for patients with a score of 4 was limited due to a small sample size. RESULTS: A total of 1536 patients were identified using NSQIP, and 163 patients were assessed in the institutional dataset. There were 518 patients with a score of 0 (455 NSQIP, 63 institutional), 676 patients with a score of 1 (617 NSQIP, 59 institutional), 391 patients with a score of 2 (364 NSQIP, 27 institutional), 106 with a score of 3 (93 NSQIP, 13 institutional), and 8 patients with a score of 4 (7 NSQIP, 1 institutional). No difference was found in the receiver operating characteristic area under the curves between datasets (P = .78). Thirty-day mortality was 10% NSQIP vs 22% institutional for a score of 0; 28% NSQIP vs 36% institutional for a score of 1; 41% NSQIP vs 44% institutional for a score of 2; 45% NSQIP vs 69% institutional for a score of 3; and 57% NSQIP vs 100% institutional for a score of 4. Score 0 was the only score with a significant mortality rate difference between datasets (P = .01). CONCLUSIONS: The modified HRS is confirmed to be broadly applicable as a clinical decision-making tool for patients presenting with rAAAs. Therefore, this easily applicable model should be applied for all patients presenting with rAAAs to assist with provider and patient decision-making prior to proceeding with repair.
引用
- Warren AS, Dansey K, Starnes BW, et al. Modified Harborview Risk Score accurately predicts mortality for patients with ruptured abdominal aortic aneurysm. J Vasc Surg. 2023. PMID: 37967587. doi:10.1016/j.jvs.2023.11.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。